Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 22540172)

1.

No autoimmune safety signal after vaccination with quadrivalent HPV vaccine Gardasil?

Tomljenovic L, Shaw CA.

J Intern Med. 2012 Nov;272(5):514-5; author reply 516. doi: 10.1111/j.1365-2796.2012.02551.x. Epub 2012 May 24. No abstract available.

PMID:
22540172
2.

Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects.

Grimaldi-Bensouda L, Guillemot D, Godeau B, Bénichou J, Lebrun-Frenay C, Papeix C, Labauge P, Berquin P, Penfornis A, Benhamou PY, Nicolino M, Simon A, Viallard JF, Costedoat-Chalumeau N, Courcoux MF, Pondarré C, Hilliquin P, Chatelus E, Foltz V, Guillaume S, Rossignol M, Abenhaim L; PGRx-AID Study Group.

J Intern Med. 2014 Apr;275(4):398-408. doi: 10.1111/joim.12155. Epub 2013 Nov 22.

PMID:
24206418
3.

Safety of quadrivalent human papillomavirus vaccine.

Omer SB.

J Intern Med. 2012 Feb;271(2):177-8. doi: 10.1111/j.1365-2796.2011.02481.x. Epub 2011 Dec 11. No abstract available.

PMID:
22077556
4.

Quadrivalent HPV vaccination reactions--more hype than harm.

Douglas RJ.

Aust Fam Physician. 2009 Mar;38(3):139-42.

5.

Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years.

Einstein MH, Baron M, Levin MJ, Chatterjee A, Edwards RP, Zepp F, Carletti I, Dessy FJ, Trofa AF, Schuind A, Dubin G; HPV-010 Study Group.

Hum Vaccin. 2009 Oct;5(10):705-19. Epub 2009 Oct 14.

6.

Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine.

Chao C, Klein NP, Velicer CM, Sy LS, Slezak JM, Takhar H, Ackerson B, Cheetham TC, Hansen J, Deosaransingh K, Emery M, Liaw KL, Jacobsen SJ.

J Intern Med. 2012 Feb;271(2):193-203. doi: 10.1111/j.1365-2796.2011.02467.x. Epub 2011 Nov 15.

PMID:
21973261
7.
9.

HPV vaccines and autoimmune diseases.

Shoenfeld Y.

J Intern Med. 2012 Jul;272(1):98; author reply 99. doi: 10.1111/j.1365-2796.2012.02537.x. Epub 2012 Mar 30. No abstract available.

PMID:
22462661
10.

CNS demyelination and quadrivalent HPV vaccination.

Sutton I, Lahoria R, Tan I, Clouston P, Barnett M.

Mult Scler. 2009 Jan;15(1):116-9. doi: 10.1177/1352458508096868. Epub 2008 Sep 19.

PMID:
18805844
11.

The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine gardasil.

Haupt RM, Sings HL.

J Adolesc Health. 2011 Nov;49(5):467-75. doi: 10.1016/j.jadohealth.2011.07.003. Epub 2011 Sep 9.

PMID:
22018560
12.

HPV vaccines and pregnancy: the situation in early 2012.

[No authors listed]

Prescrire Int. 2012 Jun;21(128):154-7. Review.

PMID:
22822594
13.

Efficacy of human papillomavirus vaccines: a systematic quantitative review.

Medeiros LR, Rosa DD, da Rosa MI, Bozzetti MC, Zanini RR.

Int J Gynecol Cancer. 2009 Oct;19(7):1166-76. doi: 10.1111/IGC.0b013e3181a3d100. Review.

PMID:
19823051
14.

The GARDASIL vaccine can prevent cervical carcinoma caused by human papilloma virus (HPV) (results from our participation and from the study carried out in Greece).

Ansstasiou-Fotaki P, Deligeoroglou E, Kreatsas G.

Akush Ginekol (Sofiia). 2007;46(3):17-20. Bulgarian, English.

PMID:
18018777
15.

Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial.

Reisinger KS, Block SL, Lazcano-Ponce E, Samakoses R, Esser MT, Erick J, Puchalski D, Giacoletti KE, Sings HL, Lukac S, Alvarez FB, Barr E.

Pediatr Infect Dis J. 2007 Mar;26(3):201-9.

PMID:
17484215
16.

Gardasil: Introducing the new human papillomavirus vaccine.

McLemore MR.

Clin J Oncol Nurs. 2006 Oct;10(5):559-60.

PMID:
17063609
17.

Human papillomavirus vaccines.

Schmiedeskamp MR, Kockler DR.

Ann Pharmacother. 2006 Jul-Aug;40(7-8):1344-52. Epub 2006 Jul 18. Review.

PMID:
16849621
18.

Safety of the quadrivalent human papillomavirus vaccine.

Brotherton JM.

BMJ. 2013 Oct 9;347:f5631. doi: 10.1136/bmj.f5631. No abstract available.

PMID:
24108153
19.

Quadrivalent Human Papillomavirus recombinant vaccine associated lipoatrophy.

Ojaimi S, Buttery JP, Korman TM.

Vaccine. 2009 Aug 6;27(36):4876-8. doi: 10.1016/j.vaccine.2009.06.026. Epub 2009 Jun 23.

PMID:
19555713
20.

Assessing human papillomavirus vaccine efficacy and safety.

Hendrix SL.

J Am Osteopath Assoc. 2008 Apr;108(4 Suppl 2):S8-S12. Review.

PMID:
18463363
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk